Literature DB >> 3917782

Who gets renal bone disease before beginning dialysis?

T Cundy, D J Hand, D O Oliver, C G Woods, F W Wright, J A Kanis.   

Abstract

To identify patients at risk from renal bone disease we compared the demographic characteristics of 243 patients with end stage renal failure grouped according to the presence (97 (40%] or absence of severe renal bone disease as judged by histological criteria. Youth, female sex, tubulointerstitial types of nephropathy, and a long duration of uraemia were all identified as significant independent risk factors for the development of bone disease. The relative risks from being female and having tubulointerstitial renal disease were separately identifiable when the estimated observation of renal failure was short (less than four years). The identification of patients at high risk from bone disease may clarify the pathogenesis and treatment strategies of renal osteodystrophy.

Entities:  

Mesh:

Year:  1985        PMID: 3917782      PMCID: PMC1417569          DOI: 10.1136/bmj.290.6464.271

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  27 in total

1.  Bone histology in incipient and advanced renal failure.

Authors:  H H Malluche; E Ritz; H P Lange; L Kutschera; M Hodgson; U Seiffert; W Schoeppe
Journal:  Kidney Int       Date:  1976-04       Impact factor: 10.612

2.  Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency.

Authors:  E B Mawer; C M Taylor; J Backhouse; G A Lumb; S W Stanbury
Journal:  Lancet       Date:  1973-03-24       Impact factor: 79.321

3.  Hypocalcaemia and bone disease in renal failure.

Authors:  M Cochran; L Bulusu; A Horsman; L Stasiak; B E Nordin
Journal:  Nephron       Date:  1973       Impact factor: 2.847

4.  Hyperparathyroid bone disease in children undergoing long-term hemodialysis; treatment with vitamin D.

Authors:  D E Potter; C J Wilson; M B Ozonoff
Journal:  J Pediatr       Date:  1974-07       Impact factor: 4.406

5.  Parathyroid disease in long-term maintenance hemodialysis.

Authors:  J P Pendras
Journal:  Arch Intern Med       Date:  1969-09

6.  Plasma gonadotropins after administration of LH-releasing hormone in patients with renal or hepatic failure.

Authors:  D S Schalch; D Gonzalez-Barcena; A J Kastin; L Landa; L A Lee; M T Zamora; A V Schally
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

7.  Role of acidosis in renal osteomalacia.

Authors:  M Cochran; B E Nordin
Journal:  Br Med J       Date:  1969-05-03

8.  Azotaemic renal osteodystrophy: a quantitative study on iliac bone.

Authors:  H A Ellis; K M Peart
Journal:  J Clin Pathol       Date:  1973-02       Impact factor: 3.411

9.  Vitamin-D deficiency in the osteomalacia of chronic renal failure.

Authors:  J B Eastwood; T C Stamp; E Harris; H E de Wardener
Journal:  Lancet       Date:  1976-12-04       Impact factor: 79.321

10.  Effects of age, sex, and polycystic disease on progressive bone disease of renal failure.

Authors:  J F Moorhead; G L Tatler; R A Baillod; Z Varghese; M R Wills; S C Farrow
Journal:  Br Med J       Date:  1974-12-07
View more
  6 in total

1.  The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.

Authors:  Naro Ohashi; Toshihiko Uematsu; Satoru Nagashima; Mitsutaka Kanamaru; Akashi Togawa; Akira Hishida; Eiji Uchida; Tadao Akizawa; Shozo Koshikawa
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

Review 2.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy.

Authors:  Feng-Xiang Yan; M Chris Langub; Mark A Ihnen; Carlton Hornung; Erkki Juronen; Mary K Rayens; Wei-Min Cai; Peter J Wedlund; Paolo Fanti
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

4.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11

Review 5.  Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.

Authors:  Bradley A Warady; Eric Ng; Laura Bloss; May Mo; Franz Schaefer; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2020-05-04       Impact factor: 3.714

Review 6.  Hyperparathyroid bone disease in chronic renal failure.

Authors:  T Cundy; N Hamdy; R Gray; B Jackson; J A Kanis
Journal:  Ulster Med J       Date:  1985-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.